Drawing for NORMAMED

USPTO serial 86290320

NORMAMED

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HSU, FONG
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NORMAMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clemens Kochinke

CLEMENS KOCHINKE BERLINER, CORCORAN & ROWE, LLP1101 17TH ST NW STE 1100WASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
038Providing information in the field of telecommunications, namely, providing information about the Internet; providing multiple-user access to a global computer information network, namely, providing electronic platforms and portals on the Internet; transmission of messages and pictures via computer; delivery of messages by electronic transmission; tele-text services; electronic transmission of messages; rental of equipment for telecommunication; web messaging, namely, forwarding of all kinds of messages to Internet addressesACTIVE—
042Scientific and technological services and research relating thereto for medical procedures, namely, scientific analysis of medical information relating to medical laboratory procedures, providing information about medical research; industrial analysis and research, namely, medical research and research into procedures, both for laboratory analysis in medical facilities; integrative consultancy for individuals and companies, namely, advising clinics, hospitals and physicians in the field of medical research, medical laboratory procedures; consultancy for surgeries for medical research purposesACTIVE—
044Medical consultation, namely, advisory service for medics making medical and clinical analysis; rental of medical equipment; tele-medical-services; consultancy for surgeries for medical treatment and diagnosis purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 16, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 15, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 13, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2015EX1GSOU EXTENSION 1 GRANTED—
Jun 11, 2015EXT1SOU EXTENSION 1 FILED—
Jun 11, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 18, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 18, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 16, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 14, 2014ALIEASSIGNED TO LIE—
Sep 27, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Sep 26, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 26, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 26, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2014DOCKASSIGNED TO EXAMINER—
Jun 5, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 27, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance